The difference is that FDA approvals are a well-defined process with specific and actionable criteria for the release of a new product. Whereas this is the administration running on vibes and favouritism
I'm not going to defend the administration on most things, but your characterization isn't entirely fair. The record seems to suggest that the administration deferred to Amazon and the NSA, which seems sensible.
Perhaps you can fault them with not coming up with an objective framework earlier, but that's a different criticism.
